Amphastar Pharmaceuticals
AMPH
#5787
Rank
A$1.82 B
Marketcap
A$42.68
Share price
0.50%
Change (1 day)
8.50%
Change (1 year)

EPS for Amphastar Pharmaceuticals (AMPH)

EPS in 2026 (TTM): A$2.57

According to Amphastar Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$2.63. In 2025 the company made an earnings per share (EPS) of A$3.17 a decrease over its 2024 EPS that were of A$4.97.

EPS history for Amphastar Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$2.57-19.11%
2025A$3.17-36.17%
2024A$4.9715.85%
2023A$4.2951.87%
2022A$2.8343.85%
2021A$1.963521.88%
2020A$0.05423-96.55%
2019A$1.57-900%
2018A-$0.20-238.6%
2017A$0.14-60.92%
2016A$0.36
2014A-$0.37

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tonix Pharmaceuticals
TNXP
A-$19.55-843.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
A-$7.86-398.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Marinus Pharmaceuticals
MRNS
A-$3.54-234.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
A-$5.85-322.41%๐Ÿ‡บ๐Ÿ‡ธ USA